RE: Level2 data.25 Nov 2024 11:53
Maybe my sells at 2.58p weren’t such a bad thing Street all eh EmC?
Feel is going to drop further - not because I want to buy back on lower as I’ve still got £40k in - but confidence in sales figures is naturally going to be low. Unless you’re a mad ramper of course.
Think the results will shift the sp significantly in one direction or the other. I don’t see the sp staying still more for a few weeks so there are going to be opportunities with the volatility. Hope everyone makes good decisions for themselves.
If there have been any sales over the past six months that could shift the sp then they should have been announced in an RNS. There has only been one such RNS which announced sales of roughly £100k per year. On top of existing sales of £50k per year and small sales here, there and everywhere I’m hoping for £250k globally per year now.
The real problem with sentiment here is that the key goal of achieving a national roll out with the NHS keeps being pushed back as more and more data gathering studies are announced. The other problem is silence on the De Novo process being commenced for FDA approval. Basically there are no clear timelines for investors to go by in terms of investing short, mid or long term. Well, I suppose if you’re going to invest long term it doesn’t matter when you jump in, you just have to accept the inevitable dips and risks of another placing. I’m thinking there will need to be one more placing but that that might be the last one before meaningful sales are achieved via a full roll out with NHS and FDA news.
Even if Gino just stated that they are going to kick start the FDA process in January that would give a huge shot in the arm to the share price as we now know the result of that application could be known in as little as 3 months.
But for now however I fear it’s a case of sit tight and hold tight.